Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 721-732 of 1,909
Drug study icon
CompletedNCT01858948

SGA-induced Metabolic Syndrome in Bipolar Youth

This summary needs review. Please check the official study record and contact the research team for details.

In Cincinnati
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 10 Years to 17 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Bipolarity
Other study type icon
CompletedNCT01076361

Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Anchorage
Why is this study shown?

This study is directly about Bipolarity.

BipolarityObservationalA study where researchers collect information without assigning a treatment.
Countries
United States, Australia, France, ...
Sponsor
Medtronic
Condition
Bipolarity
Drug study icon
RecruitingNCT07172516

Azetukalner for depression in bipolarity

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Germany, ...

Multiple locations, including Tucson
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Bulgaria, Germany, ...
Sponsor
Xenon Pharmaceuticals Inc.
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT06372964

Lumateperone for depression in bipolarity

The registry lists this study as recruiting. Study locations are listed in the United States, in Colombia, in India, ...

Multiple locations, including Dothan
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 10 Years to 17 Years
Countries
United States, Colombia, India, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT04777357

Change for depression

The registry lists this study as recruiting. Study locations are listed in the United States and in Russia.

Multiple locations, including Anaheim
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 10 Years to 17 Years
Countries
United States, Russia
Sponsor
AbbVie
Condition
Bipolarity, Depression
Drug study icon
RecruitingNCT06706232

Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolarity II Depression and Suicide prevention

This study is looking at whether questionnaires and follow-up can help people with Bipolarity II, Depression in bipolarity, or Suicide prevention. Participants receive a study treatment and complete follow-up visits and assessments.

In Houston
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Depression, ...DrugFrom 25 Years to 70 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity, Depression, ...
Drug study icon
RecruitingNCT05838274

Acute Alcohol Response In Bipolarity: a Longitudinal Alcohol Administration/fMRI Study

This study is looking at whether a digital support tool can help people with bipolarity, Alcohol Drinking, or Addiction. Participants take part in a digital support tool and complete follow-up assessments.

In Austin
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, AddictionOtherFrom 21 Years to 26 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Bipolarity, Addiction
Biological study icon
RecruitingNCT03522545

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Depression in bipolarity

This study is comparing Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) with placebo for people with Treatment-resistant Depression in bipolarity. Participants receive Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) or placebo and complete study visits and assessments.

In Houston
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityBiologicalFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Depression, Bipolarity
Drug study icon
RecruitingNCT06656416

ALTO-100 in Bipolarity With Depression (BD-D)

This study is looking at care and outcomes for people with bipolarity I or II With a Major Depressive Episode. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

Multiple locations, including Phoenix
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.